# Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

> **NCT07304466** · NA · RECRUITING · sponsor: **Istanbul Medipol University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Liver Transplantation
- Portal Hypertension

## Interventions

- **DRUG:** Somatostatin
- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT07304466
- **Lead sponsor:** Istanbul Medipol University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-03-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07304466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07304466, "Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07304466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*